Nutraceutical Alternatives to Pharmaceutical Analgesics in Osteoarthritis

S. Heffernan, G. Conway
{"title":"Nutraceutical Alternatives to Pharmaceutical Analgesics in Osteoarthritis","authors":"S. Heffernan, G. Conway","doi":"10.5772/INTECHOPEN.95919","DOIUrl":null,"url":null,"abstract":"Chronic pain is a considerable health concern worldwide, effecting almost 30% of all European adults. Osteoarthritis (OA), a progressive pro-inflammatory condition, is one of the leading causes of chronic pain (effecting 13% of all those over 50 years, globally) and is the most common cause of joint pain. The prevalence of non-steroidal anti-inflammatory drug (NSAIDs) and analgesic use has been well studied and is abundant throughout the western world, with women being the greatest users and ibuprofen generally being the most reported NSAID. In the US, 65% of all OA patients are prescribed NSAIDs for pain management and form part of the current recommended strategy for OA clinical management. While some NSAIDs and analgesics are effective at improving pain and physical function, they come with significant and harmful side effects such as gastrointestinal complications, renal disturbances and severe cardiovascular events. Given these side-effects, any reduction in NSAID and analgesia use (and the resulting potentially harmful side effects) is of particular importance to OA public health. As such, a number of non-pharmaceutical alternatives (bioactive nutraceuticals) have been developed that may reduce NSAID and analgesia use while maintaining pain reduction and improvements in physical function. This chapter will discuss select nutraceuticals that are not currently in mainstream use but may have the potential to aid in the treatment of OA.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"74 6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Management - Practices, Novel Therapies and Bioactives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.95919","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Chronic pain is a considerable health concern worldwide, effecting almost 30% of all European adults. Osteoarthritis (OA), a progressive pro-inflammatory condition, is one of the leading causes of chronic pain (effecting 13% of all those over 50 years, globally) and is the most common cause of joint pain. The prevalence of non-steroidal anti-inflammatory drug (NSAIDs) and analgesic use has been well studied and is abundant throughout the western world, with women being the greatest users and ibuprofen generally being the most reported NSAID. In the US, 65% of all OA patients are prescribed NSAIDs for pain management and form part of the current recommended strategy for OA clinical management. While some NSAIDs and analgesics are effective at improving pain and physical function, they come with significant and harmful side effects such as gastrointestinal complications, renal disturbances and severe cardiovascular events. Given these side-effects, any reduction in NSAID and analgesia use (and the resulting potentially harmful side effects) is of particular importance to OA public health. As such, a number of non-pharmaceutical alternatives (bioactive nutraceuticals) have been developed that may reduce NSAID and analgesia use while maintaining pain reduction and improvements in physical function. This chapter will discuss select nutraceuticals that are not currently in mainstream use but may have the potential to aid in the treatment of OA.
骨关节炎药物镇痛的营养替代品
慢性疼痛是世界范围内一个相当大的健康问题,影响着几乎30%的欧洲成年人。骨关节炎(OA)是一种进行性促炎疾病,是慢性疼痛的主要原因之一(全球50多年来影响13%的患者those),也是关节疼痛的最常见原因。非甾体抗炎药(NSAIDs)和镇痛药的使用已经得到了很好的研究,并且在整个西方世界都很普遍,女性是最大的使用者,布洛芬通常是最多的reported NSAID。在美国,65%的OA患者使用非甾体抗炎药来治疗疼痛,这也是OA临床治疗当前推荐策略的一部分。虽然一些非甾体抗炎药和镇痛药在改善疼痛和身体功能方面是有效的,但它们会产生严重的有害副作用,如胃肠道并发症、肾脏紊乱和严重的心血管事件。鉴于这些副作用,减少非甾体抗炎药和镇痛药的使用(以及由此产生的潜在有害副作用)对OA公共卫生尤为重要。因此,许多非药物替代品(生物活性营养品)已经开发出来,可以减少非甾体抗炎药和止痛药的使用,同时保持疼痛减轻和身体功能的改善。本章将讨论目前尚未被主流使用但可能有潜力帮助治疗OA的营养保健品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信